Skip to content

"Neurodevelopment outcomes in very low birth weight infants following zinc supplementation"

"Neurodevelopment outcomes at 2-3 years of age in very low birth weight infants following zinc supplementation"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037234
Enrollment
60
Registered
2021-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P84- Other problems with newborn Health Condition 2: P84- Other problems with newborn

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: This follow up study includes Very low birth weight babies previously enrolled in a randomized control trial on Zinc supplementation for short term outcomes. These children will be followed up at 2-3 years of age for neurodevelopmental outcomes. It was done by Dr Nikhil Tenneti( EC/06/18/1362), DNB Fellow, Department of Neonatology at Sir Ganga Ram Hospital, New Delhi.

Exclusion criteria

Exclusion criteria: Refusal of Consent or lost to follow up

Design outcomes

Primary

MeasureTime frame
Neurodevelopmental outcomes at 2-3 years of age as assessed by Bayley Scales of Infancy and Toddler Development (BSID) or Ages and Stages Questionnaire (ASQ) where an in person appointment is not feasible.Timepoint: Single time point (2-3 years of age)

Secondary

MeasureTime frame
NoneTimepoint: None

Countries

India

Contacts

Public ContactDr Neelam Kler

Sir Ganga Ram Hospital

drneelamkler@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026